Pancreatic Cancer Research

ResearcherIRCCS Humanitas Research HospitalActive in the last 2 years

Filippo Alongi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6569-8628; OpenAlex author ID A5011844809. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Th… Co-author DOI 10.1016/j.ijrobp.2025.03.046↗
  2. Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy. Last author DOI 10.1007/s11547-021-01422-z↗
  3. Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study. First author DOI 10.3390/biomedicines8120609↗
  4. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery. Last author DOI 10.1007/s00066-018-1306-2↗
  5. Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body Radiation Therapy" [Critical Reviews in O… Co-author DOI 10.1016/j.critrevonc.2016.12.010↗
  6. Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy. Co-author DOI 10.1016/j.critrevonc.2016.05.003↗
  7. SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. Co-author DOI 10.1186/1748-717x-8-148↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosario Mazzola · 4 shared papers, 2016–2022 · strength 0.35
  2. Fabiana Gregucci · 2 shared papers, 2018–2022 · strength 0.21
  3. Jacobien C.M. Scheepens · 1 shared paper, 2025 · strength 0.20
  4. William Adrian Hall · 1 shared paper, 2025 · strength 0.20
  5. Lois A. Daamen · 1 shared paper, 2025 · strength 0.20
  6. Jasmijn Maria Westerhoff · 1 shared paper, 2025 · strength 0.20
  7. Uffe Bernchou · 1 shared paper, 2025 · strength 0.20
  8. Gert J. Meijer · 1 shared paper, 2025 · strength 0.20
  9. Beth E. Erickson · 1 shared paper, 2025 · strength 0.20
  10. Berardino De Bari · 2 shared papers, 2016–2017 · strength 0.14
  11. Mahmut Özşahin · 2 shared papers, 2016–2017 · strength 0.14
  12. Markus Schäfer · 2 shared papers, 2016–2017 · strength 0.14
  13. Antonio Pea · 1 shared paper, 2020 · strength 0.10
  14. Luca Nicosia · 1 shared paper, 2020 · strength 0.10
  15. Vincenzo Corbo · 1 shared paper, 2020 · strength 0.10
  16. Sabrina L. D’Agosto · 1 shared paper, 2020 · strength 0.10
  17. Rita Teresa Lawlor · 1 shared paper, 2020 · strength 0.10
  18. Aldo Scarpa · 1 shared paper, 2020 · strength 0.10
  19. A. Tozzi · 1 shared paper, 2013 · strength 0.03
  20. Pietro Mancosu · 1 shared paper, 2013 · strength 0.03
  21. Tiziana Comito · 1 shared paper, 2013 · strength 0.03
  22. Alessandro Zerbi · 1 shared paper, 2013 · strength 0.03
  23. Marta Scorsetti · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.